Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer’s Disease

Nanoparticle-based magnetic contrast agents have opened the potential for magnetic resonance imaging (MRI) to be used for early non-invasive diagnosis of Alzheimer’s disease (AD). Accumulation of amyloid pathology in the brain has shown association with cognitive decline and tauopathy; hence, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulanova, Marina, Gloag, Lucy, Bongers, Andre, Kim, Chul-Kyu, Duong, Hong Thien Kim, Kim, Ha Na, Gooding, John Justin, Tilley, Richard D., Biazik, Joanna, Wen, Wei, Sachdev, Perminder S., Braidy, Nady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527350/
https://www.ncbi.nlm.nih.gov/pubmed/37759500
http://dx.doi.org/10.3390/cells12182279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527350/
https://www.ncbi.nlm.nih.gov/pubmed/37759500
http://dx.doi.org/10.3390/cells12182279

Ejemplares similares